Ikaria, Inc. is a critical care company focused on developing and commercializing innovative therapies (drugs and devices) designed to address the significant needs of critically ill patients. The company’s lead product is INOMAX® (nitric oxide) for inhalation, the only FDA-approved drug for the tre...See more
Headquarters:
Company Type:
MNC / Large Enterprise
Company size:
501-1,000 Employees
Year Founded:
2007 (18 years)
Address:
null
At a glanceHIGH
spending power
